Obesity phenotypes and atherogenic dyslipidemias
Atherogenic dyslipidemias are a hallmark of high-risk obesity phenotypes and a major contributor to ASCVD within the CKM framework. Precision medicine approaches that incorporate obesity phenotyping, targeted treatment strategies and population-level interventions are needed to reduce the burden of dyslipidemias and their cardiovascular sequelae.
Authors
- Soo Kyung Lim (ORCID: https://orcid.org/0000-0002-4137-1671)
- Hun Jee Choe (ORCID: https://orcid.org/0000-0001-5318-0859)
- Talal Almas (ORCID: https://orcid.org/0000-0002-8867-600X)
- Ian J. Neeland (ORCID: https://orcid.org/0000-0003-2831-3618)
- J. Després
Institutions
- University Hospitals of Cleveland (US)
- Seoul National University Bundang Hospital (KR)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Hallym University Dongtan Sacred Heart Hospital (KR)
- University School (US)
- Centres Intégré Universitaires de Santé et de Services Sociaux (CA)
- Université Laval (CA)
- Case Western Reserve University (US)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-11-21
- DOI
- https://doi.org/10.1111/eci.70151
- Citations
- 3
- Primary Topic
- Adipokines, Inflammation, and Metabolic Diseases
- Type
- article
- Field-Weighted Citation Impact
- 4.06